151 related articles for article (PubMed ID: 17671111)
1. Molecular pathways for cancer angioprevention.
Albini A; Noonan DM; Ferrari N
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4320-5. PubMed ID: 17671111
[TBL] [Abstract][Full Text] [Related]
2. Tumor inflammatory angiogenesis and its chemoprevention.
Albini A; Tosetti F; Benelli R; Noonan DM
Cancer Res; 2005 Dec; 65(23):10637-41. PubMed ID: 16322203
[TBL] [Abstract][Full Text] [Related]
3. [Targeting angiogenesis in oncology].
Fayette J; Soria JC; Armand JP
Pathol Biol (Paris); 2006 May; 54(4):199-205. PubMed ID: 16753494
[TBL] [Abstract][Full Text] [Related]
4. Tumor angiogenesis--a potential target in cancer chemoprevention.
Bhat TA; Singh RP
Food Chem Toxicol; 2008 Apr; 46(4):1334-45. PubMed ID: 17919802
[TBL] [Abstract][Full Text] [Related]
5. The HMG-CoA reductase pathway, statins and angioprevention.
Feng C; Han A; Ye C; Xu R; Li M
Semin Ophthalmol; 2006; 21(1):29-35. PubMed ID: 16517442
[TBL] [Abstract][Full Text] [Related]
6. Biologic therapy of breast cancer: focus on co-inhibition of endocrine and angiogenesis pathways.
Roy V; Perez EA
Breast Cancer Res Treat; 2009 Jul; 116(1):31-8. PubMed ID: 19101790
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic approaches of angiogenesis inhibition: are we tackling the problem at the right level?
Griffioen AW
Trends Cardiovasc Med; 2007 Jul; 17(5):171-6. PubMed ID: 17574125
[TBL] [Abstract][Full Text] [Related]
8. Angiogenesis: from plants to blood vessels.
Fan TP; Yeh JC; Leung KW; Yue PY; Wong RN
Trends Pharmacol Sci; 2006 Jun; 27(6):297-309. PubMed ID: 16697473
[TBL] [Abstract][Full Text] [Related]
9. Angiogenesis as a potential target of pharmaconutrients in cancer therapy.
Granci V; Dupertuis YM; Pichard C
Curr Opin Clin Nutr Metab Care; 2010 Jul; 13(4):417-22. PubMed ID: 20453647
[TBL] [Abstract][Full Text] [Related]
10. Molecular pathways of angiogenesis inhibition.
Tabruyn SP; Griffioen AW
Biochem Biophys Res Commun; 2007 Mar; 355(1):1-5. PubMed ID: 17276388
[TBL] [Abstract][Full Text] [Related]
11. Molecular mechanisms and therapeutic development of angiogenesis inhibitors.
Cao Y
Adv Cancer Res; 2008; 100():113-31. PubMed ID: 18620094
[TBL] [Abstract][Full Text] [Related]
12. Antiangiogenic therapy for cancer: an update.
Shojaei F; Ferrara N
Cancer J; 2007; 13(6):345-8. PubMed ID: 18032969
[TBL] [Abstract][Full Text] [Related]
13. [Anti-angiogenesis drugs as a potential approach in cancer therapy].
Sela B
Harefuah; 2000 Oct; 139(7-8):283-9. PubMed ID: 11062974
[No Abstract] [Full Text] [Related]
14. Pathways mediating resistance to vascular endothelial growth factor-targeted therapy.
Ellis LM; Hicklin DJ
Clin Cancer Res; 2008 Oct; 14(20):6371-5. PubMed ID: 18927275
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of tumor angiogenesis by a natural fragment of a tRNA synthetase.
Tzima E; Schimmel P
Trends Biochem Sci; 2006 Jan; 31(1):7-10. PubMed ID: 16297628
[TBL] [Abstract][Full Text] [Related]
16. Small-molecule and antibody approaches to molecular chemotherapy of primary brain tumors.
Newton HB
Curr Opin Investig Drugs; 2007 Dec; 8(12):1009-21. PubMed ID: 18058572
[TBL] [Abstract][Full Text] [Related]
17. Angiogenesis: molecular mechanisms of activation, promotion and maintenance.
Bikfalvi A
J BUON; 2007 Sep; 12 Suppl 1():S59-66. PubMed ID: 17935279
[TBL] [Abstract][Full Text] [Related]
18. [Neoplasms under control with the help of vascular treatment?].
Laurén J; Alitalo K
Duodecim; 2000; 116(7):705-11. PubMed ID: 12078136
[No Abstract] [Full Text] [Related]
19. [Angiogenesis: all a radiation oncologist should know].
Mazeron R; Bourhis J; Deutsch E
Cancer Radiother; 2008 Jan; 12(1):50-60. PubMed ID: 18243753
[TBL] [Abstract][Full Text] [Related]
20. Angiogenesis in malignancy.
Cao Y
Semin Cancer Biol; 2009 Oct; 19(5):277-8. PubMed ID: 19945648
[No Abstract] [Full Text] [Related]
[Next] [New Search]
